Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s):  MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.


CSE:MDMA - Post by User

Post by AjarnEvanon Mar 11, 2023 11:57am
213 Views
Post# 35332545

In July this is going to fly

In July this is going to flyLong time lurker here.

If you didn't get th chance to see the AMA with Nick on CEO.ca it's worth your time to scrolling up and checking it out. It's impossible not to see the potential of this company and the moves that it's made in the last two years. Some of these plans will be coming to fruition in July and until then we're going to experience the usual pop and retractions that I can't predict with any certainty. What is certain, of course, is that the naysayers will begin to appear in droves (although it's probably just an obnoxious sociopath with multiple accounts) to try to convince you to sell. And by all means, take some profits off the table but understand that first mover advantage is a real thing in this case. There are several ex-cannabis sector members on the team and they have learned regulatory issues and lived through the ridiculous cannabis boom and deflation. I expect them to be able to navigate the upcoming regulatory changes, the competition of peers, and deliver that sweet MDMA product to the people.

Don't get scared of the pullback and think to the future.

Good luck.
<< Previous
Bullboard Posts
Next >>